Gelofusine

Gelofusine is a volume expander that is used as a blood plasma replacement if a significant amount of blood is lost due to extreme hemorrhaging, trauma, dehydration, or a similar event.[1] Gelofusine is a 4% w/v solution of succinylated gelatine (also known as modified fluid gelatine) used as an intravenous colloid, and behaves much like blood filled with albumins.[2] As a result, it causes an increase in blood volume, blood flow, cardiac output, and oxygen transportation.[3]

Administration

The dosage is adjusted according to the amount of blood loss. Initially, 500 to 1000 ml is administered on average, and higher doses are applied for more severe blood loss. In children, the safety and efficacy of Gelofusine has not yet been established. Gelofusine is contraindicated in cases of hypersensitivity to the components of the drug, hypervolemia and hyperhydration.[4] (broken link to reference - needs updating)

References

  1. ↑ Platt, Sam (1 September 2002). "Intravenous fluids: the options". Nursing Times. Retrieved 29 September 2009.
  2. ↑ "Gelofusine, B. Braun Medical" (PDF). Archived from the original (PDF) on 11 January 2019.
  3. ↑ "Gelofusine Flexpak". NetDoctor. Archived from the original on 14 June 2012. Retrieved 2012-06-01.
  4. ↑ "Gelofusine: Summary of product characteristics" (PDF). Archived from the original (PDF) on 31 August 2018. Retrieved 31 August 2018.


This page is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.